ROSSI, OLIVIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.276
EU - Europa 1.070
AS - Asia 1.037
SA - Sud America 123
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 20
OC - Oceania 12
Totale 3.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.233
IT - Italia 369
RU - Federazione Russa 358
CN - Cina 331
SG - Singapore 277
HK - Hong Kong 101
BR - Brasile 94
KR - Corea 88
VN - Vietnam 88
PL - Polonia 61
FR - Francia 49
IN - India 40
IE - Irlanda 39
DE - Germania 33
GB - Regno Unito 29
JP - Giappone 29
CA - Canada 24
NL - Olanda 24
SE - Svezia 24
FI - Finlandia 23
ES - Italia 20
ID - Indonesia 18
CH - Svizzera 14
AU - Australia 12
JO - Giordania 11
IL - Israele 10
AR - Argentina 7
BD - Bangladesh 7
MX - Messico 7
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
EC - Ecuador 5
JM - Giamaica 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
LT - Lituania 4
NG - Nigeria 4
TH - Thailandia 4
UA - Ucraina 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BJ - Benin 3
EG - Egitto 3
MA - Marocco 3
PY - Paraguay 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
IQ - Iraq 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
UY - Uruguay 2
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.539
Salva come PNG Salva come JPEG
Città #
Santa Clara 243
Ashburn 226
Singapore 190
Hefei 104
San Jose 100
Seoul 88
Hong Kong 85
Milan 79
Warsaw 60
Fairfield 46
Beijing 41
Dublin 39
Florence 39
Moscow 30
Ho Chi Minh City 29
Council Bluffs 28
Rome 26
Cambridge 23
Chandler 23
Wilmington 22
Buffalo 21
Hanoi 21
The Dalles 21
Houston 20
Los Angeles 20
Seattle 20
Dallas 19
Shanghai 19
Lauterbourg 18
Woodbridge 18
Madrid 15
Altamura 14
Lawrence 14
New York 14
Zurich 14
Frankfurt am Main 13
Kent 13
Munich 13
Chicago 12
Helsinki 12
Luni 12
Mumbai 11
São Paulo 11
Tokyo 11
Chennai 10
Jakarta 10
Melbourne 9
Orem 9
Osaka 9
Paris 9
Tel Aviv 9
Guangzhou 8
London 8
Phoenix 8
Ann Arbor 7
Lappeenranta 7
Princeton 7
Bari 6
Bengaluru 6
San Diego 6
Boston 5
Genoa 5
Haiphong 5
Livorno 5
Xi'an 5
Abuja 4
Alba 4
Amman 4
Amsterdam 4
Boardman 4
Brooklyn 4
Johannesburg 4
Montreal 4
Palermo 4
Philadelphia 4
Tashkent 4
Toronto 4
Turku 4
Washington 4
Baku 3
Bogotá 3
Bắc Ninh 3
Campi Bisenzio 3
Catania 3
Clifton 3
Cotonou 3
Denver 3
Hyderabad 3
Hải Dương 3
Jeddah 3
Las Vegas 3
Modena 3
Naples 3
Ninh Bình 3
Parma 3
Reggio Emilia 3
Roubaix 3
Saint-Mandé 3
Aioichō 2
Athens 2
Totale 2.167
Salva come PNG Salva come JPEG
Nome #
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations 332
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 260
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 231
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 208
Migrants and allergy: a new view of the atopic march 187
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 178
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 173
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 172
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 172
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 170
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 165
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 164
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 163
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 157
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 155
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 143
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 136
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 131
Asthma phenotype can be influenced by recurrent respiratory infections in patients with primary antibody deficiency: the impact of Ig therapy 116
Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC 110
Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes 46
Totale 3.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 2 0 11 0 1 6 4 8 13
2022/2023175 12 37 13 6 5 27 25 12 17 4 7 10
2023/2024195 2 12 20 18 28 17 10 38 4 20 9 17
2024/2025977 28 90 55 144 226 98 46 57 60 29 51 93
2025/20261.722 238 211 234 200 147 45 185 64 76 100 67 155
2026/2027210 68 45 97 0 0 0 0 0 0 0 0 0
Totale 3.569